Scientific Publications

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Publication TypeJournal Article
AuthorsDutt, A., Ramos AH, Hammerman PS, Mermel C., Cho J., Sharifnia T., Chande A., Tanaka KE, Stransky N., Greulich H., Gray NS, and Meyerson M.
AbstractSquamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma.
Year of Publication2011
JournalPloS one
Volume6
Issue6
Pagese20351
Date Published (YYYY/MM/DD)2011/01/01
DOI10.1371/journal.pone.0020351
PubMedhttp://www.ncbi.nlm.nih.gov/pubmed/21666749?dopt=Abstract